Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment
Hua Liu,1,2,* Yang-Min Hao,1,2,* Sheng Jiang,1,2,* Maiheliya Baihetiyaer,1,2 Cheng Li,3 Guo-Yao Sang,4 Zhiming Li,5 Guo-Li Du1,2,6 1State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, Urumqi, Xinjiang, People’s Republic of China; 2D...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2024-06-01
|
| Edice: | International Journal of General Medicine |
| Témata: | |
| On-line přístup: | https://www.dovepress.com/evaluation-of-masld-fibrosis-fib-4-and-apri-score-in-masld-combined-wi-peer-reviewed-fulltext-article-IJGM |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
